CLS CELESTICA INC
Printed Circuit Boards · NYSE · SEC CIK 1030894 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY61.6%
TTM net income YoY73.8%
TTM EPS YoY72.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin11.5%
Operating margin8.3%
Net margin6.8%
FCF margin3.0%
EBITDA margin9.3%
Returns
ROE30.2%
ROA11.5%
ROIC (approx.)46.2%
Asset turnover1.68x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.13x
Current ratio1.61x
Interest coverage20.36x
Cash quality & payout
Operating cash flow / net income1.13x
Accruals ratio-1.5%
Payout ratio—
Capex / revenue4.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $12.39B | $9.65B | $7.96B | $7.25B | $5.63B |
| Cost of revenue | $10.90B | $8.61B | $7.21B | $6.60B | $5.15B |
| Gross profit | $1.49B | $1.03B | $754.10M | $649.70M | $487.00M |
| R&D expense | $118.20M | $78.00M | $60.90M | $46.30M | $38.40M |
| SG&A expense | $259.90M | $293.50M | $303.20M | $267.30M | $245.10M |
| Operating income | $1.04B | $599.30M | $338.30M | $289.30M | $167.70M |
| Interest expense | $52.60M | $52.10M | $78.90M | $51.70M | $31.70M |
| Pretax income | $983.20M | $532.20M | $306.00M | $239.10M | $136.00M |
| Income tax | $150.70M | $104.20M | $61.60M | $59.00M | $32.10M |
| Net income | $832.50M | $428.00M | $244.40M | $180.10M | $103.90M |
| EBITDA | $1.22B | $751.20M | $469.10M | $405.20M | $294.00M |
| EPS (basic) | 7.22 | 3.62 | 2.03 | 1.46 | 0.82 |
| EPS (diluted) | 7.16 | 3.61 | 2.03 | 1.46 | 0.82 |
| Weighted avg. shares (diluted) | 116.20M | 118.70M | 120.30M | 123.60M | 126.70M |
| Banking | |||||
| Deposits | — | — | $904.80M | $825.60M | $434.00M |
| Balance sheet | |||||
| Cash & equivalents | $595.60M | $423.30M | $370.40M | $374.50M | $394.00M |
| Receivables | — | — | $1.80B | $1.39B | $1.26B |
| Inventory | $2.19B | $1.76B | $2.10B | $2.35B | $1.70B |
| Current assets | $5.67B | $4.51B | $4.51B | $4.33B | $3.44B |
| PP&E, net | $586.00M | $537.20M | $524.00M | $371.50M | $338.70M |
| Goodwill | $333.10M | $340.50M | $321.70M | $321.80M | $324.20M |
| Intangibles | $266.20M | $308.00M | $318.30M | $346.50M | $382.00M |
| Total assets | $7.21B | $5.99B | $5.89B | $5.63B | $4.67B |
| Current liabilities | $3.94B | $3.02B | $3.22B | $3.06B | $2.25B |
| Short-term debt | $26.00M | $26.50M | $27.00M | — | — |
| Long-term debt | $750.50M | $770.20M | $648.30M | — | — |
| Total debt | $776.50M | $796.70M | $675.30M | — | — |
| Total liabilities | $5.00B | $4.09B | $4.12B | $3.95B | $3.20B |
| Shareholders' equity | $2.22B | $1.90B | $1.77B | $1.68B | $1.46B |
| Net debt | $180.90M | $373.40M | $304.90M | — | — |
| Shares outstanding | 114.91M | 116.07M | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | $659.50M | $473.90M | $326.20M | $211.10M | $226.80M |
| Capital expenditure | $201.20M | $170.90M | $125.10M | $109.00M | — |
| Free cash flow | $458.30M | $303.00M | $201.10M | $102.10M | — |
| Investing cash flow | -$203.70M | -$212.50M | -$122.40M | -$108.90M | -$364.30M |
| Financing cash flow | -$283.50M | -$208.50M | -$207.90M | -$121.70M | $67.70M |
| Depreciation & amortization | $175.70M | $151.90M | $130.80M | $115.90M | $126.30M |
| Stock-based compensation | $69.80M | $57.40M | $55.60M | $51.00M | $33.40M |
| Share buybacks | $153.40M | $152.00M | $35.60M | $34.60M | — |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.